SCHEMBL169397

SCHEMBL169397

NOC(=O)[C@@H](N)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL876613 1.00
SCHEMBL5310988 0.97
Hydrochloric Acid SCHEMBL396086 0.97
Acetic Acid SCHEMBL6244288 0.91 PTGS1 (0.50)
SCHEMBL1964879 0.86 PTGS1 (0.55)
SCHEMBL20657045 0.86 PTGS1 (0.55)
Hydrochloric Acid SCHEMBL11053790 0.84 PTGS1 (0.52)
Hydrochloric Acid SCHEMBL11053789 0.84 PTGS1 (0.52)
SCHEMBL11125227 0.82 PTGS1 (0.50)
SCHEMBL462748 0.81 PTGS1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6002 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399229-A2 CD28 SHEDDING BLOCKING AGENTS Biond Biologics Ltd. (IL) 2024-07-17 EP claimed
WO-2024148000-A2 METHODS FOR PREDICTING AND EVALUATING FOOD FUNCTIONS IN PROTEINS AND COMPOSITIONS Prose Foods, Inc. (US) 2024-07-11 WO claimed
US-20240233865-A1 METHODS FOR PREDICTING AND EVALUATING FOOD FUNCTIONS IN PROTEINS AND COMPOSITIONS PROSE FOODS INC. 2024-07-11 US claimed
WO-2024115767-A1 NOMACOPAN-PAS FUSION PROTEINS VOLUTION IMMUNO PHARMACEUTICALS SA (CH) 2024-06-06 WO claimed
EP-3612207-B1 COVERSIN VARIANTS LACKING C5 BINDING VOLUTION IMMUNO PHARMACEUTICALS SA (CH) 2024-04-10 EP claimed
WO-2024064756-A1 RECEPTOR-MEDIATED ENDOCYTOSIS FOR TARGETED INTERNALIZATION AND DEGRADATION OF MEMBRANE PROTEINS AND CARGOS DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-03-28 WO claimed
WO-2024064754-A1 RECEPTOR-MEDIATED ENDOCYTOSIS FOR TARGETED DEGRADATION AND DELIVERY OF THERAPEUTIC AGENTS DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-03-28 WO claimed
EP-3506877-B1 CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS LABORATOIRE BIOSTHETIQUE KOSMETIK GMBH & CO KG (DE) 2024-03-27 EP claimed
US-20240082135-A1 PEPTIDE COMPOSITION AND RESPECTIVE USES UNIVERSIDADE DO MINHO (PT) 2024-03-14 US claimed
EP-3733277-B1 PATTERNED SUBSTRATE HAVING HYDROPHILIC AND HYDROPHOBIC AREAS KARLSRUHER INSTITUT FUER TECH KIT (DE) 2024-02-21 EP claimed
US-5663294-A ANTICOAGULANT OLIGOPEPTIDES OR POLYPEPTIDES TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1997-09-02 US claimed
EP-0789768-A1 RESPIRATORY SYNCYTIAL VIRUS PROTEIN G EXPRESSED ON BACTERIAL MEMBRANE PIERRE FABRE MEDICAMENT (FR) 1997-08-20 EP claimed
WO-1997025620-A1 A METHOD AND USE OF POLYPEPTIDE IN SPERM-EGG BINDING TO ENHANCE OR DECREASE FERTILITY THE PENN STATE RESEARCH FOUNDATION (US) 1997-07-17 WO claimed
EP-0677584-B1 Stable mutants of D-N-alpha-carbamylase ENIRICERCHE SPA (IT) 1996-12-11 EP claimed
WO-1996023883-A2 MODIFIED LIGANDS FOR RECEPTOR TYROSINE KINASES BERLEX LABORATORIES, INC. (US) 1996-08-08 WO claimed
WO-1996014418-A1 RESPIRATORY SYNCYTIAL VIRUS PROTEIN G EXPRESSED ON BACTERIAL MEMBRANE PIERRE FABRE MEDICAMENT (FR) 1996-05-17 WO claimed
EP-0677584-A1 Stable mutants of D-N-alpha-carbamylase ENIRICERCHE S.p.A. (IT) 1995-10-18 EP claimed
US-5405769-A Modified by introduction of intermolecular or intramolecular disulfide bridge and/or tyrosine or phenylalanine in N-terminal region NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1995-04-11 US claimed
WO-1995002328-A1 MAMMALIAN LOW MOLECULAR WEIGHT PHOSPHOLIPASE A2 NUCLEOTIDE AND AMINO ACID SEQUENCES INDIANA UNIVERSITY FOUNDATION (US) 1995-01-26 WO claimed
EP-0082789-B1 IMMUNOLOGICAL COMPOSITION AND METHOD FOR HEPATITIS B VIRUS Baylor College of Medicine (US) 1987-04-08 EP claimed